Our results indicate that inhibition of FoxM1 expression significantly suppresses the tumorigenicity of human glioblastoma cells, whereas rescue the Anxa1 expression can recover the ability of tumorigenicity. This evidence concerns the gene ANXA1 and glioblastoma.